Looking at real world evidence on PSA testing in prostate cancer

Bortezomib and dexamethasone demonstrate efficacy benefit in key subgroups vs daratumumab, bortezomib, and dexamethasone in RRMM

Safety and quality of life assessment, how do they impact patient decision? KCCure survey – part B

Grand Rounds: Improving quality of patient-centred care

Avelumab plus platinum-based chemotherapy may show some efficacy in patients with extensive-stage small cell lung cancer

Addition of atezolizumab to chemotherapy after surgery does not improve survival for triple negative breast cancer

EBCC 2024: Addressing inequalities across Europe in access to innovation for patients with metastatic breast cancer

Comment: EBCC 2024 highlights

Saruparib shows encouraging efficacy and safety in mutant advanced solid tumours

Linvoseltamab induces deep and durable responses in patients with relapsed or refractory multiple myeloma

Do patients and doctors treatment aspirations align? KCCure survey – part A

Darolutamide, androgen-deprivation therapy and docetaxel demonstrate promising efficacy mHSPC